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Arthroscopic second generation autologous chondrocyte 
implantation at 48 months follow-up 
E. Kon, G. Filardo, M. Delcogliano, S. Zaffagnini, C. Montaperto, F. 
Iacono, M. Marcacci, Italy 
Autologous Chondrocyte Implantation (ACI) proposed by Brittberg in 
1994 [1], involving re-implantation of autologous cells that have been 
isolated from cartilage harvested from the patient and expanded in 
WJUSP JT HBJOJOHXJEF TDJFOUJ¾D BOE DMJOJDBM TVQQPSU GPS VTF JO UIF
repair of focal articular cartilage lesions. A second-generation tissue-
engineering approach to cartilage repair was proposed, which uses 
a biodegradable three-dimensional scaffold for cell proliferation. 
This scaffold is entirely based on the benzylic ester of hyaluronic 
acid (HYAFF® 11, Fidia Advanced Biopolymers Laboratories, Padova, 
*UBMZ
BOEDPOTJTUTPGBOFUXPSLPGNUIJDL¾CFSTXJUIJOUFSTUJDFT
of variable sizes, and has been demonstrated to be an optimal 
physical support to allow cell-cell contacts, cluster formation, and 
extracellular matrix deposition [2,3,4]. The cells harvested from the 
patient are expanded and then seeded onto the scaffold to create the 
tissue-engineered product Hyalograft C. Seeded on the scaffold the 
cells are able to re-differentiate and retain a chondrocytic phenotype 
even after a long period of in vitro expansion in monolayer culture 
<>5IFFG¾DBDZPGUIFDFMMTDBGGPMEDPOTUSVDUXBTBMTPQSPWFO
by in vivo implantation in an animal model [3]. Hyalograft C constructs 
DBO CF JNQMBOUFE CZ QSFTT¾UUJOH EJSFDUMZ JOUP UIF MFTJPO UIVT
avoiding suturing to surrounding cartilage and obviating the need 
GPSBQFSJPTUFBM¿BQ<>.PSFPWFSUIFGFBUVSFTPGUIJTEFWJDFIBWF
permitted the development of an arthroscopic surgical technique 
for implantation of autologous chondrocytes on a hyaluronic acid 
support with the aim of reducing patient morbidity, surgical time and 
recovery and complications related to open surgery [9]. The results 
of Hyalograft C implantation under open procedure without the use 
PGBQFSJPTUFBM¿BQBSFFODPVSBHJOH<>)JTUPMPHJDBMBOBMZTJTPG
biopsies obtained from the patients who had undergone autologous 
chondrocyte culture and Hyalograft C application without a periosteal 
coverage, have shown a hyaline-like cartilage in the implant zone just 
12 months after the implant [10,11, 13]. The purpose of this study is 
to study the possibility of treating femoral condyle chondral lesions 
with arthroscopic implantation of Hyalograft C and analyze the 
indication criteria for this type of treatment. For this purpose a group 
of 54 consecutive patients treated by the arthroscopic technique 
was prospectively evaluated at a minimum of four years follow-up. 
Patient selection. Arthroscopic techniques have been developed 
and used in our Institute since 2001. Clinical experimentation was 
approved by the Hospital Ethics Committee and informed consent of 
all patients was obtained. The treatment was indicated in patients 
with focal chondral defects involving femoral condyles and trochlea, 
complaining of clinical symptoms (pain, swelling, locking, and giving 
way). Exclusion criteria were age <15 and >60 years, untreated tibio-
femoral or patello-femoral malalignment or instability, diffused 
arthritis or bipolar (“kissing”) lesions, and those with other general 
medical conditions (diabetes, rheumatoid arthritis, etc). All patients 
gave their consent to participate and comply with the required 
post-operative rehabilitation regimen and were included in the 
study. All the patients were consecutively treated and prospectively 
evaluated. 54 consecutive patients treated by arthroscopy with 
a minimum of 48 months follow-up were prospectively evaluated. 
The lesions treated were single in 51 cases and multiple in 3 cases 
(medial femoral condyle combined with trochlea lesions in 2 cases 
and medial and lateral condyle lesions in one case). 38 chondral 
defects were situated on the medial condyle, 15 on the lateral 
femoral condyle, and 4 on the trochlea. All lesions were Outerbridge 
grade III-IV and the mean size of the lesions was 2.4 cm2. (1.5-5 
cm2). The etiology was traumatic in 27 cases, degenerative in 20 
cases, and 7 patients were affected by osteochondritis dissecans. 
The mean age of the patients was 29 years (range 15 - 60 years). The 
patients practiced sport at a highly competitive level in 19 cases, at 
amateur level in 29 cases, while 6 patients did not practice any type 
of sport. 22 patients underwent previous surgery: 7 meniscectomies, 
8 ACL reconstructions and 8 cartilage repair operations, such 
as shaving, debridement or microfracturing of chondral lesions 
and mosaicplasty. In 26 patients associated procedures were 
performed during cartilage harvesting: 18 ACL reconstructions, 17 
meniscectomies, 3 meniscal sutures, 1 collagen meniscus implant 
(Tab.1). In OCD cases, 5 patients presented a 10-12 mm deep defect 
and were treated with arthroscopic autologous bone grafting during 
the cartilage harvesting procedure. In remaining 2 OCD cases with 3-
7 mm deep bone defect no associated procedures were performed. 
In 21 cases the meniscus was partially removed from the same 
compartment of the chondral lesion during previous or associated 
surgery. The number of Hyalograft C patches used was between 
1 and 4, of 2 different diameters (6.5 mm-8.5 mm). Chondrocyte 
harvesting and culturing The surgical technique for ACI consists of 
UXPTUFQT5IF¾STUQSPDFEVSFDPOTJTUTPGBCJPQTZPGIFBMUIZDBSUJMBHF
for autologous chondrocyte cell culture. This is usually performed 
arthroscopically, when the chondral lesion has been observed, and 
the indication for ACI has been made. A 150-200 mg cartilage biopsy 
is taken from a non-weight bearing site of the articular surface 
(intercondylar notch) and sent to the processing center in a serum-
free nutritional medium. The following day the tissue is minced into 
smaller pieces and digested with 0.25% trypsin at 37 °C for 15 min 
and then with 300 U/ml collagenase type II (Worthington, Lakewood, 
NJ, USA) at 37 °C for 4 hr in Ham’s F12. The digested material is 
centrifuged at 1000 rpm for 10 min and the pellet is resuspended 
in Ham’s F12 containing 10% fetal calf serum (Sigma), 1% penicillin-
streptomycin, 1% L-glutamine, 1 ng/ml TGFȕ 1, 1 ng/ml insulin, 1 ng/
ml EGF, and 10 ng/ml bFGF (all growth factors were recombinant and 
of human sequence). Typically from 200 mg of tissue 1 – 2 million 
DFMMTBSFSFDPWFSFE$FMMTBSFBNQMJ¾FEJONPOPMBZFSDVMUVSFTVQUP
three passages, then they were seeded onto Hyalograft C scaffolds 
(2 x 2 cm). 8 x 106 cells are resuspended in 0.4 ml of medium (as 
above, but containing 50 ïg/ml ascorbic acid), the cell suspension is 
pipetted onto the scaffold and the culture is kept at 37 °C, 5% CO2 
overnight, The next day, additional medium is added to submerge 
the cell construct completely, whereas the medium is changed twice 
a week. Hyalograft CÒ chondrocyte cultures are ready for shipment 
after 2 weeks in culture. The day of shipment the cell construct is 
washed exhaustively with PBS then sealed in a sterile plastic tray 
containing 4 ml of nutritional medium. The expiry time of the product 
is 72 hr. Arthroscopic surgical technique According to the technique 
developed [9] a variable diameter (6.5 mm – 8.5 mm) delivery device 
with a sharp edge is used to evaluate the size of the defect in order 
UPFOTVSFBDPNQMFUFDPWFSBHFPGUIFEFGFDU"¿JQQFEDBOOVMBUIBU
BMMPXTUIFSFNPWBMPGUIFGBUQBEGSPNPQFSBUJWF¾FMEJTUIFOJOTFSUFE
JOUPUIFBOUFSPNFEJBMQPSUBMBOEBTQFDJ¾DBMMZEFTJHOFEDBOOVMBUFE
MPXQSP¾MFESJMM	NN°NN
NBJOUBJOFEJOUIFTFMFDUFEQPTJUJPO
by a Kirschner guide wire (0.9 mm diameter), is used to debride 
the lesion and make a circular area with regular margins for graft 
JNQMBOUBUJPO5IFEFMJWFSZEFWJDFJTUIFO¾MMFEXJUIBIZBMVSPOJDBDJE
patch, which is transported and positioned in the prepared area. The 
graft is pushed out of the delivery device and precisely positioned 
XJUIJOUIFEFGFDUXIFSFJUSFNBJOT¾YFEUJHIUMZUPUIFTVCDIPOESBM
bone. The stamps can be overlapped, but the positioning inside 
the prepared circular area with good shoulder healthy cartilage 
coverage is mandatory. Under arthroscopic control the stability of 
implanted stamps is evaluated also during cyclic bending of the 
knee. Mobilization of the implanted patch was not observed in our 
series (Fig. 1). Follow-up evaluation All 54 patients were clinically 
prospectively evaluated preoperatively and at 24 and 48 months 
follow-up. The 28 patients with isolated chondral lesions were 
evaluated separately and compared to the patients who underwent 
associated procedures. The International Cartilage Repair Society 
Evaluation Package [14] was used for clinical evaluation. Patients 
were also asked to evaluate their quality of life using the EQ-VAS 
score [15]. Returning back to sport was also recorded at 24 and 48 
months follow up, evaluated with Tegner Score and compared with 
pre-operative and pre-injury level. At a follow-up of 12-36 months, 11 
second-look arthroscopies was performed, with patient consent, for 
investigative purposes to check visually and probe for consistency of 
UIFJNQMBOUFEDBSUJMBHF3FQBJSUJTTVFRVBMJUZXBTDMBTTJ¾FEBDDPSEJOH
to the Brittberg score[16]. During the second-look arthroscopy, full-
depth biopsies of cartilage and subchondral bone were obtained 
from the repair site in 2 patients, who expressed their consent for 
a follow-up biopsy. As the grading of matrix protein abundance 
by histological analyses alone may be misleading [17], both 
histological and quantitative biochemical analyses were performed 
on each biopsy [18] assays and total collagen was measured as 
hydroxyproline by amino acid analysis [13,17]. Statistical Methods 
All continuous variables were expressed in terms of mean ± standard 
deviation of the mean. The Paired t test was performed to test the 
hypotheses about means at different follow up times when the data 
were normally distributed; otherwise the Wilcoxon Test was used. 
One Way ANOVA was performed to test hypotheses about means 
of different groups. The Mann Whitney Test was used to test the 
hypotheses about continuous data differences between groups 
or among groups. Rank Spearman Correlation was performed to 
investigate relationships between two quantitative measurements, 
For all tests p<XBTDPOTJEFSFETJHOJ¾DBOU4UBUJTUJDBMBOBMZTJT
was performed using SPSS 7.5 (Rizzoli Orthopaedic Institute). 
No complications related to the implant or serious adverse events 
were observed during the treatment and follow up period. A 
TUBUJTUJDBMMZ TJHOJ¾DBOU JNQSPWFNFOU JO BMM TDPSFT XBT PCTFSWFE
after 24 months. The improvements remained stable over time at 48 
NPOUIT"TUBUJTUJDBMMZTJHOJ¾DBOUJNQSPWFNFOUJOUIF*,%$PCKFDUJWF
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score was observed (Wilcoxon Test p<0,0005), showing a normal or 
nearly normal knee in 83.3 % (45/54) of patients at 24 months follow 
up and in 85 % (46/54) of patients at 24 months follow up (Tab. 
2). Worsening of IKDC objective score was observed in 2 patients 
at 48 months. One of these 2 patients underwent medial meniscal 
SFNPWBMQSFWJPVTMZ5IFSFXBTOPTUBUJTUJDBMMZTJHOJ¾DBOUEJGGFSFODF
between results at 24 and 48 months follow up. Statistical analysis 
TIPXTBTJHOJ¾DBOU JNQSPWFNFOU JO UIF *,%$TVCKFDUJWFTDPSFBOE
self-assessment of quality of life (EQ-VAS) from pre-operative to 
24 and 48 months (Paired T-test; p<
 XJUI OP TJHOJ¾DBOU
difference between 24 and 48 months (Tab. 3,4). The mean IKDC 
score improvement at 24 months was 39±23 and 39±26 at 48 
months follow up, whereas the mean improvement with the EQ-VAS 
score was 16±26 at 24 months and 19±22 at 48 months follow up. 
The mean Tegner score was 6.34 (2.2 s.d.) before the injuries, 1.72 
(1.1 s.d.) before the treatment, 4.88 (2.6 s.d.) at 24 moths follow 
up and 4.94 (2.7 s.d.) after 48 months. These results showed a 
TUBUJTUJDBMMZ TJHOJ¾DBOU JNQSPWFNFOU 	Q< 0.0005) after the surgery 
at 24 and 48 months follow up; however the new level of sport 
BDUJWJUZ	5FHOFS
XBTTJHOJ¾DBOUMZMPXFSXJUISFTQFDUUPUIFQSF
injury level (Tegner 6.34) (p<0.0005) (Tab.5). In order to establish 
the indications for this type of treatment, we tried to determine the 
QBSBNFUFSTUIBUJO¿VFODFUIFDMJOJDBMPVUDPNF4UBUJTUJDBMBOBMZTJT
(Rank Spearman Correlation) showed better results in younger 
patients with subjective IKDC evaluation at 24 (p<0,001; Rho= -
0,447) and 48 moths follow up (p<0,005; Rho= -0,377). Better 
results were also achieved in well-trained patients. Our results did 
OPUTIPXBOZTJHOJ¾DBOUEJGGFSFODFCFUXFFOQSFWJPVTMZUSFBUFEBOE
never treated patients at 48 months follow up, only at 24 moths 
there was a difference in clinical outcome, with better improvement 
PGOFWFSUSFBUFEQBUJFOUTCVUOPUTUBUJTUJDBMMZTJHOJ¾DBOU	Q
One Way Anova). The patients who underwent associated surgery 
had similar clinical results to patients with isolated chondral lesions. 
0UIFSGBDUPSTTVDIBTEFGFDUTJ[FBOEMPDBMJ[BUJPOEJEOPUJO¿VFODF
TJHOJ¾DBOUMZUIFSFTVMUT"SUISPTDPQJDFWBMVBUJPOSFWFBMFEBDPNQMFUF
coverage of the grafted area with a hyaline cartilage-like tissue, 
¾MMJOHPG UIFEFGFDUBOE JOUFHSBUJPOXJUI UIFPSJHJOBMTVSSPVOEJOH
cartilage in 7 of 11 analyzed cases. In 2 cases poor integration of 
the new cartilage with the border zone and in 3 cases irregularity 
of cartilage surface was found. Mean Brittberg defect repair score 
was 10.5. We undertook histological evaluation of the regenerating 
tissue, albeit after a short follow up of 12 months. In these 2 cases 
there was clear evidence of regenerated cartilage that was hyaline in 
POFDBTFBOE¾CSPDBSUJMBHFJOUIFPUIFS<>#PUITQFDJNFOTTIPXFE
close integration of the engineered cartilage with the subchondral 
bone. Moreover, a clear presence of a tidemark, which is typical of 
hyaline cartilage and is rarely seen in cartilage repair biopsies, was 
observed particularly in one case [18]. 
The arthroscopic autologous chondrocyte implantation technique 
XBTEFWFMPQFE JO UIFBUUFNQU UP JNQSPWF UIFFG¾DBDZBOE SFEVDF
the morbidity of the ACI technique, which still remains for us one of 
the main concerns of this technique [19]. Recent prospective studies 
<>IBWFOPUDPNQMFUFMZDMBSJ¾FEUIFCFUUFSQFSGPSNBODFPGUIF
ACI technique compared to other procedures used for cartilage repair. 
Knutsen [22], in particular, reported similar results for microfracture 
and traditional ACI technique at 2 years follow up. The necessity to 
create a hermetic periosteum seal using sutures, the requirement 
of a second open surgery and possible complications related to the 
VTFPGBQFSJPTUFBM¿BQDBOFYQMBJO UIFTF SFTVMUT5IFSF JTBOFFE
for a large joint exposure wich increases morbidity for the patients 
BOEQSPEVDFTBIJHIFS SJTLPG KPJOUTUJGGOFTTBOEBSUISP¾CSPTJTBT
frequently observed with this procedure. Periosteal hypertrophy 
occurs between 3 and 7 months after surgery in 10-25% of cases 
and often requires revision surgery [23,16]. Some authors [19] have 
shown a reoperation rate of up to 42%, due to joint stiffness. Some 
BVUIPST<>IBWFJOEJDBUFEUIBUUIFVTFPGUIFQFSJPTUFBM¿BQ
increases the risk of complications during the recovery period and 
QSPEVDFTNPSFEJG¾DVMUSFIBCJMJUBUJPO5IFNPTUGSFRVFOUNPUJWBUJPO
for revision surgery is the incomplete periosteal graft incorporation 
to the host cartilage and hypertrophic graft edge response. The 
use of a three-dimensional scaffold for the cell culture with open 
surgery already permits a reduction of joint exposure because it 
avoids periosteal harvesting and suturing. The development of the 
arthroscopic technique reduces morbidity for the patient, recovery 
time and rehabilitation protocol, thus facilitating recovery for the 
patients. Arthroscopic autologous chondrocyte transplantation 
maintains the advantage of the osteochondral grafting arthroscopic 
procedures, while the disadvantages of donor site morbidity can be 
avoided, particularly when we have to treat large defects. In fact, 
it is possible to treat more extensive lesions without problems of 
material availability. Moreover, patches can be overlapped to create 
a complete coverage of the defect without leaving uncovered interval 
spaces typically observed in lesions treated with osteochondral 
grafting. No implant related complications were noted in this study. 
Even in cases where more than 2 patches were used with overlapping 
of the grafts, no symptoms related to overgrowth or hypertrophy 
were observed. Satisfactory clinical results were achieved at 2 and 4 
years follow-up in our series, and only patients with femoral condyle 
or troclear chondral lesions, treated by arthroscopic surgery, were 
considered to form a homogeneous group. Patients with patellar or 
tibial plateau lesions were excluded from the study in order to avoid 
bias. We noted that the results with bioengineered cartilage were 
better in young patients who practiced sport at a highly competitive 
level. This observation can be correlated to the greater commitment 
PGUIJTQBUJFOUUPUIFSFIBCJMJUBUJPOQSPHSBNCVUBMTPDPO¾SNTUIF
possible functional recovery of the knee after this procedure that 
meets the high functional request of competitive athletes. The 
patients were not permitted to return to the sport activity before 
12 months in order to guarantee initial cartilage tissue stability and 
maturation. This fact can be a disadvantage for athletes with highly 
competitive requests and necessity of the quick return to sport 
activity. The results were not compromised by associated surgery, 
which suggests that this procedure may be combined successfully 
with different surgical operations. All the associated procedures 
were performed in the same surgical session as cartilage harvesting, 
in order to avoid surgical stress and favour the rehabilitation 
QSPHSBN PG DIPOESPDZUF JNQMBOUBUJPO /P TUBUJTUJDBMMZ TJHOJ¾DBOU
difference respect to the group with associated lesions was detected. 
This suggests that the clinical improvement of these patients was 
SFMBUFEUPUIFDBSUJMBHFTVSHFSZ"OZXBZJUJTWFSZEJG¾DVMUUPTUBCJMJ[F
UIF JO¿VFODF PG DPODPNJUBOU MFTJPOT PO UIF DMJOJDBM PVUDPNF BOE
the number of the patients who underwent associated surgery 
represents one of the most important biases of this study. We have 
noticed also that our results were not affected by defect size. In fact, 
satisfactory results were obtained also in large cartilage lesions. 
We suppose that there are theoretically no limits for the size of the 
defect that can be treated with this technique. The limits are related 
to the technical execution of the procedure and the presence of intact 
cartilage shoulder around the implantation area. We undertook 
histological evaluation of the regenerating tissue, albeit after a 
TIPSUGPMMPXVQPGNPOUIT0VS¾OEJOHTXFSFFYBDUMZJOMJOFXJUI
those we have published previously showing 50% hyaline cartilage 
BOE¾CSPDBSUJMBHF <> *O UIFQSFTFOU BSUISPTDPQJD TUVEZ UIF
number of biopsies for histological examination was low (n=2) for 
ethical reasons. The biopsies were only taken in those patients who 
clearly expressed their consent for the osteochondral biopsy for 
investigation purposes. In these 2 cases there was clear evidence of 
SFHFOFSBUFEDBSUJMBHFUIBUXBTIZBMJOFJOPOFDBTFBOE¾CSPDBSUJMBHF
in the other. The technical limit of the arthroscopic technique is 
UIFEJG¾DVMUZ UP USFBU MFTJPOT MPDBUFEPO UIFQBUFMMBBOEQPTUFSJPS
portion of femoral condyle. However, it should be noted that this 
limit is common to all arthroscopic techniques and could be partly 
solved only with development of new arthroscopic tools. In general, 
however, the autologous chondrocyte implant on three-dimensional 
scaffolds guarantees results comparable with the traditional ACI 
technique, but reduces the morbidity of the procedure and avoids 
UIFVTFPGBQFSJPTUFBM¿BQXJUINBSLFEBEWBOUBHFTGSPNBCJPMPHJDBM
and surgical point of view. The clinical and histological results of our 
¾STUQBUJFOUTBUNFEJVNGPMMPXVQBSFFODPVSBHJOH0VSQSFMJNJOBSZ
results suggest this method may be used for the treatment of large 
cartilage lesions, also in highly competitive athletes, but long-term 
BOE SBOEPNJ[FE DPOUSPMMFE TUVEJFTXJMM CF OFFEFE UP DPO¾SN UIF
reliability of this procedure. 
